Study of YOLT-203 in Children and Adults With Primary Hyperoxaluria Type 1 (PH1)
Clinical trial NCT07587021 · RECRUITING
Trial details
- NCT number
- NCT07587021
- Sponsor
- YolTech Therapeutics Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2027-08-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.